CA Stock MarketDetailed Quotes
DTR DiagnosTear Technologies Inc
- 0.500
- -0.100-16.67%
15min DelayMarket Closed Dec 13 09:47 ET
29.39MMarket Cap-1.74P/E (TTM)
0.520High0.500Low2.03KVolume0.520Open0.600Pre Close1.03KTurnover0.71052wk High0.01%Turnover Ratio58.79MShares0.50052wk Low-0.288EPS TTM22.09MFloat Cap0.710Historical HighLossP/E (Static)44.18MShs Float0.500Historical Low-0.288EPS LYR3.33%Amplitude--Dividend TTM-100.00P/B1Lot Size--Div YieldTTM
DiagnosTear Technologies Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | 0.43%465K | -41.90%-1.03M | -917K | 463K | 50.54%-728K | -1.47M |
| Net income from continuing operations | -27.79%304K | 2.86%-1.15M | ---962K | --421K | 21.08%-1.19M | ---1.5M |
| Depreciation and amortization | ---- | 2.35%87K | ---- | ---- | 1.19%85K | --84K |
| Remuneration paid in stock | ---- | -67.74%10K | ---- | ---- | -29.55%31K | --44K |
| Other non cashItems | ---- | -71.57%29K | ---- | ---- | 308.00%102K | --25K |
| Change In working capital | -45.67%69K | -102.49%-6K | ---81K | --127K | 299.17%241K | ---121K |
| -Change in payables and accrued expense | 78.26%164K | -155.88%-19K | ---94K | --92K | 125.95%34K | ---131K |
| -Change in other current assets | ---- | -92.31%1K | ---- | ---- | 159.09%13K | ---22K |
| -Change in other current liabilities | ---- | -93.81%12K | ---- | ---- | 506.25%194K | --32K |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | 0.43%465K | -41.90%-1.03M | ---917K | --463K | 50.54%-728K | ---1.47M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -1,255.26%-515K | 84.10%-38K | -239K | |||
| Net PPE purchase and sale | ---- | -1,255.26%-515K | ---- | ---- | 84.10%-38K | ---239K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | ---- | -1,255.26%-515K | ---- | ---- | 84.10%-38K | ---239K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 64.21%-316K | 364.08%1.73M | 1.54M | -883K | -43.05%373K | 655K |
| Net issuance payments of debt | ---- | 5.38%-88K | ---- | ---- | 0.00%-93K | ---93K |
| Net common stock issuance | 80.06%-185K | 290.34%1.82M | --1.63M | ---928K | -37.70%466K | --748K |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 64.21%-316K | 364.08%1.73M | --1.54M | ---883K | -43.05%373K | --655K |
| Net cash flow | ||||||
| Beginning cash position | 357.14%256K | -81.12%98K | --72K | --56K | -67.19%519K | --1.58M |
| Current changes in cash | -133.33%-36K | 146.56%183K | --111K | --108K | 62.78%-393K | ---1.06M |
| Effect of exchange rate changes | ---- | 78.57%-6K | ---- | ---- | -300.00%-28K | ---7K |
| End cash Position | -98.61%1K | 180.61%275K | --275K | --72K | -81.12%98K | --519K |
| Free cash from | -52.98%466K | -102.09%-1.55M | ---1.43M | --991K | 55.23%-766K | ---1.71M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data